CERo Therapeutics Holdings, Inc.
CERO
$0.01
$0.00-9.91%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.28% | -775.79% | -14.86% | -121.23% | -122.02% |
| Total Depreciation and Amortization | 2.45% | -2.99% | -8.24% | -8.73% | -6.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 440.87% | 106.95% | 42.17% | 145.47% | 121.32% |
| Change in Net Operating Assets | 408.81% | -92.49% | -42.78% | -163.11% | 92.22% |
| Cash from Operations | 37.89% | -147.15% | -16.19% | -30.70% | 12.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.98% | 116.48% | -- | -- | -62.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 166.24% | 117.70% | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -647.28% | 59.83% | -100.00% | -- |
| Cash from Financing | -69.06% | 131.79% | -42.83% | 5.06% | -11.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.89% | -577.40% | -379.99% | -100.92% | -9.68% |